Abbott India Shareholders Approve All Resolutions at 81st Annual General Meeting
Abbott India Limited held its 81st Annual General Meeting on August 13, 2025, via video conferencing. Shareholders approved all proposed resolutions, including the adoption of financial statements, declaration of a final dividend, reappointment of directors, appointment of secretarial auditors, ratification of cost auditor remuneration, and appointment of Mr. Kartik Rajendran as Director and Managing Director for five years. The voting process, conducted through NSDL, saw overwhelming support for all resolutions, with most receiving over 99% votes in favor. The company promptly submitted voting results and the scrutinizer's report to BSE Limited, demonstrating commitment to transparency and good corporate governance.
*this image is generated using AI for illustrative purposes only.
Abbott India Limited , a prominent pharmaceutical company, successfully conducted its 81st Annual General Meeting (AGM) on August 13, 2025, through video conferencing. The meeting saw shareholders approving all proposed resolutions with the required majority, marking a significant milestone for the company.
Key Resolutions Approved
The shareholders gave their nod to several important resolutions, including:
Adoption of Financial Statements: The audited financial statements for the year ended March 2025 were adopted.
Dividend Declaration: A final dividend per equity share was declared, although the specific amount was not disclosed in the available information.
Director Reappointments: Ms. Alison Davies and Mr. Kaiyomarz Marfatia, who retired by rotation, were reappointed as directors.
Appointment of Secretarial Auditors: BNP & Associates were appointed as secretarial auditors for five consecutive financial years.
Cost Auditor Remuneration: The remuneration of the cost auditor was ratified.
New Managing Director: Mr. Kartik Rajendran was appointed as Director and Managing Director for a period of five years, from June 2025 to June 2030.
Voting Process and Scrutiny
The AGM was conducted with both remote e-voting and e-voting facilities provided through National Securities Depository Limited (NSDL). Mr. Husain Wagh of Khumri Wagh Fatehi & Associates LLP served as the scrutinizer for the voting process, ensuring transparency and accuracy.
Detailed Voting Results
The consolidated scrutinizer's report revealed that all resolutions received overwhelming support from the shareholders. Here's a breakdown of the voting results for key resolutions:
| Resolution | Votes in Favor (%) | Votes Against (%) |
|---|---|---|
| Adoption of Financial Statements | 99.99 | 0.01 |
| Declaration of Final Dividend | 100.00 | 0.00 |
| Reappointment of Ms. Alison Davies | 99.80 | 0.20 |
| Reappointment of Mr. Kaiyomarz Marfatia | 99.80 | 0.20 |
| Appointment of Secretarial Auditors | 99.99 | 0.01 |
| Ratification of Cost Auditor Remuneration | 99.99 | 0.01 |
| Appointment of Mr. Kartik Rajendran as Director | 99.99 | 0.01 |
| Appointment of Mr. Kartik Rajendran as Managing Director | 99.78 | 0.22 |
The strong support for all resolutions indicates shareholders' confidence in the company's management and future direction.
Compliance and Disclosure
In compliance with regulatory requirements, Abbott India Limited promptly submitted the voting results and the consolidated scrutinizer's report to the BSE Limited. This adherence to transparency norms underscores the company's commitment to good corporate governance practices.
The successful conclusion of the 81st AGM, with all resolutions passed, positions Abbott India Limited for continued growth and development in the pharmaceutical sector. Shareholders' approval of the new Managing Director's appointment and other key resolutions reflects their trust in the company's strategic decisions and future prospects.
Historical Stock Returns for Abbott
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.99% | +1.67% | -3.00% | +19.49% | +22.96% | +101.99% |
16
